240 related articles for article (PubMed ID: 8710867)
1. The solution structure of the Raf-1 cysteine-rich domain: a novel ras and phospholipid binding site.
Mott HR; Carpenter JW; Zhong S; Ghosh S; Bell RM; Campbell SL
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8312-7. PubMed ID: 8710867
[TBL] [Abstract][Full Text] [Related]
2. The cysteine-rich region of raf-1 kinase contains zinc, translocates to liposomes, and is adjacent to a segment that binds GTP-ras.
Ghosh S; Xie WQ; Quest AF; Mabrouk GM; Strum JC; Bell RM
J Biol Chem; 1994 Apr; 269(13):10000-7. PubMed ID: 8144497
[TBL] [Abstract][Full Text] [Related]
3. Solution structure of a cysteine rich domain of rat protein kinase C.
Hommel U; Zurini M; Luyten M
Nat Struct Biol; 1994 Jun; 1(6):383-7. PubMed ID: 7664052
[TBL] [Abstract][Full Text] [Related]
4. Solution structure and functional analysis of the cysteine-rich C1 domain of kinase suppressor of Ras (KSR).
Zhou M; Horita DA; Waugh DS; Byrd RA; Morrison DK
J Mol Biol; 2002 Jan; 315(3):435-46. PubMed ID: 11786023
[TBL] [Abstract][Full Text] [Related]
5. Chemical shift assignments and folding topology of the Ras-binding domain of human Raf-1 as determined by heteronuclear three-dimensional NMR spectroscopy.
Emerson SD; Waugh DS; Scheffler JE; Tsao KL; Prinzo KM; Fry DC
Biochemistry; 1994 Jun; 33(25):7745-52. PubMed ID: 8011639
[TBL] [Abstract][Full Text] [Related]
6. Comparison of chemical characteristics of the first and the second cysteine-rich domains of protein kinase C gamma.
Irie K; Yanai Y; Oie K; Ishizawa J; Nakagawa Y; Ohigashi H; Wender PA; Kikkawa U
Bioorg Med Chem; 1997 Aug; 5(8):1725-37. PubMed ID: 9313873
[TBL] [Abstract][Full Text] [Related]
7. Peptides containing a consensus Ras binding sequence from Raf-1 and theGTPase activating protein NF1 inhibit Ras function.
Clark GJ; Drugan JK; Terrell RS; Bradham C; Der CJ; Bell RM; Campbell S
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1577-81. PubMed ID: 8643674
[TBL] [Abstract][Full Text] [Related]
8. Elucidation of binding determinants and functional consequences of Ras/Raf-cysteine-rich domain interactions.
Williams JG; Drugan JK; Yi GS; Clark GJ; Der CJ; Campbell SL
J Biol Chem; 2000 Jul; 275(29):22172-9. PubMed ID: 10777480
[TBL] [Abstract][Full Text] [Related]
9. Raf-1 kinase possesses distinct binding domains for phosphatidylserine and phosphatidic acid. Phosphatidic acid regulates the translocation of Raf-1 in 12-O-tetradecanoylphorbol-13-acetate-stimulated Madin-Darby canine kidney cells.
Ghosh S; Strum JC; Sciorra VA; Daniel L; Bell RM
J Biol Chem; 1996 Apr; 271(14):8472-80. PubMed ID: 8626548
[TBL] [Abstract][Full Text] [Related]
10. 14-3-3 zeta negatively regulates raf-1 activity by interactions with the Raf-1 cysteine-rich domain.
Clark GJ; Drugan JK; Rossman KL; Carpenter JW; Rogers-Graham K; Fu H; Der CJ; Campbell SL
J Biol Chem; 1997 Aug; 272(34):20990-3. PubMed ID: 9261098
[TBL] [Abstract][Full Text] [Related]
11. Structural determinants of Ras-Raf interaction analyzed in live cells.
Bondeva T; Balla A; Várnai P; Balla T
Mol Biol Cell; 2002 Jul; 13(7):2323-33. PubMed ID: 12134072
[TBL] [Abstract][Full Text] [Related]
12. Raf-1 N-terminal sequences necessary for Ras-Raf interaction and signal transduction.
Pumiglia K; Chow YH; Fabian J; Morrison D; Decker S; Jove R
Mol Cell Biol; 1995 Jan; 15(1):398-406. PubMed ID: 7799948
[TBL] [Abstract][Full Text] [Related]
13. Structure of the Ras-binding domain of c-Raf-1 as determined by NMR spectroscopy and identification of the region that interacts with Ras.
Emerson SD; Madison VS; Palermo RE; Waugh DS; Scheffler JE; Tsao KL; Kiefer SE; Liu SP; Fry DC
Drug Des Discov; 1996 Apr; 13(3-4):83-93. PubMed ID: 8874046
[TBL] [Abstract][Full Text] [Related]
14. The strength of interaction at the Raf cysteine-rich domain is a critical determinant of response of Raf to Ras family small GTPases.
Okada T; Hu CD; Jin TG; Kariya K; Yamawaki-Kataoka Y; Kataoka T
Mol Cell Biol; 1999 Sep; 19(9):6057-64. PubMed ID: 10454553
[TBL] [Abstract][Full Text] [Related]
15. The RafC1 cysteine-rich domain contains multiple distinct regulatory epitopes which control Ras-dependent Raf activation.
Daub M; Jöckel J; Quack T; Weber CK; Schmitz F; Rapp UR; Wittinghofer A; Block C
Mol Cell Biol; 1998 Nov; 18(11):6698-710. PubMed ID: 9774683
[TBL] [Abstract][Full Text] [Related]
16. Multivalent assembly of KRAS with the RAS-binding and cysteine-rich domains of CRAF on the membrane.
Fang Z; Lee KY; Huo KG; Gasmi-Seabrook G; Zheng L; Moghal N; Tsao MS; Ikura M; Marshall CB
Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12101-12108. PubMed ID: 32414921
[TBL] [Abstract][Full Text] [Related]
17. Cysteine-rich region of Raf-1 interacts with activator domain of post-translationally modified Ha-Ras.
Hu CD; Kariya K; Tamada M; Akasaka K; Shirouzu M; Yokoyama S; Kataoka T
J Biol Chem; 1995 Dec; 270(51):30274-7. PubMed ID: 8530446
[TBL] [Abstract][Full Text] [Related]
18. KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation.
Tran TH; Chan AH; Young LC; Bindu L; Neale C; Messing S; Dharmaiah S; Taylor T; Denson JP; Esposito D; Nissley DV; Stephen AG; McCormick F; Simanshu DK
Nat Commun; 2021 Feb; 12(1):1176. PubMed ID: 33608534
[TBL] [Abstract][Full Text] [Related]
19. Zinc finger domains and phorbol ester pharmacophore. Analysis of binding to mutated form of protein kinase C zeta and the vav and c-raf proto-oncogene products.
Kazanietz MG; Bustelo XR; Barbacid M; Kolch W; Mischak H; Wong G; Pettit GR; Bruns JD; Blumberg PM
J Biol Chem; 1994 Apr; 269(15):11590-4. PubMed ID: 8157692
[TBL] [Abstract][Full Text] [Related]
20. Role of hydrophobic residues in the C1b domain of protein kinase C delta on ligand and phospholipid interactions.
Wang QJ; Fang TW; Nacro K; Marquez VE; Wang S; Blumberg PM
J Biol Chem; 2001 Jun; 276(22):19580-7. PubMed ID: 11278612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
